Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126274947 | 12627494 | 7 | F | 20160717 | 20160921 | 20160805 | 20160926 | EXP | KR-PFIZER INC-2016366831 | PFIZER | 56.00 | YR | M | Y | 0.00000 | 20160926 | MD | KR | KR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126274947 | 12627494 | 1 | SS | TREMELIMUMAB | TREMELIMUMAB | 1 | Intravenous (not otherwise specified) | 75 MG, CYCLIC (ONCE EVERY 4 WEEKS) | 225 | MG | D | 0 | 75 | MG | |||||
126274947 | 12627494 | 2 | SS | TREMELIMUMAB | TREMELIMUMAB | 1 | Intravenous (not otherwise specified) | 75 MG, CYCLIC ( ONCE EVERY 4 WEEKS) | 225 | MG | D | 0 | 75 | MG | |||||
126274947 | 12627494 | 3 | SS | TREMELIMUMAB | TREMELIMUMAB | 1 | Intravenous (not otherwise specified) | 75 MG, CYCLIC ( ONCE EVERY 4 WEEKS) | 225 | MG | D | 0 | 75 | MG | |||||
126274947 | 12627494 | 4 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 5 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 6 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 7 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 8 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 9 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 10 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 11 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 12 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 13 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 14 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 15 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 16 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 17 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 18 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 19 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 20 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 21 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 22 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 400 MG/M2 BOLUS ON DAY 1, 5FU 1200 MG/M2 IV OVER 24 H DAILY ON DAYS 1 AND 2 OF EACH CYCLE | Y | 0 | 400 | MG/M**2 | SOLUTION FOR INFUSION | ||||||
126274947 | 12627494 | 23 | PS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 85 MG/M2 IV OVER 120 MIN ON DAY 1 | Y | 78813 | 85 | MG/M**2 | |||||||
126274947 | 12627494 | 24 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 85 MG/M2 IV OVER 120 MIN ON DAY 1 | Y | 78813 | 85 | MG/M**2 | |||||||
126274947 | 12627494 | 25 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 85 MG/M2 IV OVER 120 MIN ON DAY 1 | Y | 78813 | 85 | MG/M**2 | |||||||
126274947 | 12627494 | 26 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 85 MG/M2 IV OVER 120 MIN ON DAY 1 | Y | 78813 | 85 | MG/M**2 | |||||||
126274947 | 12627494 | 27 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 85 MG/M2 IV OVER 120 MIN ON DAY 1 | Y | 78813 | 85 | MG/M**2 | |||||||
126274947 | 12627494 | 28 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 85 MG/M2 IV OVER 120 MIN ON DAY 1 | Y | 78813 | 85 | MG/M**2 | |||||||
126274947 | 12627494 | 29 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 400 MG/M2 IV OVER 120 MINUTES DAY 1 | Y | 8107 | 400 | MG/M**2 | |||||||
126274947 | 12627494 | 30 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 400 MG/M2 IV OVER 120 MINUTES DAY 1 | Y | 8107 | 400 | MG/M**2 | |||||||
126274947 | 12627494 | 31 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 400 MG/M2 IV OVER 120 MINUTES DAY 1 | Y | 8107 | 400 | MG/M**2 | |||||||
126274947 | 12627494 | 32 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 400 MG/M2 IV OVER 120 MINUTES DAY 1 | Y | 8107 | 400 | MG/M**2 | |||||||
126274947 | 12627494 | 33 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 400 MG/M2 IV OVER 120 MINUTES DAY 1 | Y | 8107 | 400 | MG/M**2 | |||||||
126274947 | 12627494 | 34 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Intravenous (not otherwise specified) | 400 MG/M2 IV OVER 120 MINUTES DAY 1 | Y | 8107 | 400 | MG/M**2 | |||||||
126274947 | 12627494 | 35 | SS | MEDI4736 | DURVALUMAB | 1 | Intravenous (not otherwise specified) | 1.5 G, CYCLIC (ONCE EVERY 4 WEEKS) | 4.5 | G | D | 0 | 1.5 | G | |||||
126274947 | 12627494 | 36 | SS | MEDI4736 | DURVALUMAB | 1 | Intravenous (not otherwise specified) | 1.5 G, CYCLIC( ONCE EVERY 4 WEEKS) | 4.5 | G | D | 0 | 1.5 | G | |||||
126274947 | 12627494 | 37 | SS | MEDI4736 | DURVALUMAB | 1 | Intravenous (not otherwise specified) | 1.5 G, CYCLIC (ONCE EVERY 4 WEEKS) | 4.5 | G | D | 0 | 1.5 | G | |||||
126274947 | 12627494 | 38 | SS | CEFPODOXIME PROXETIL. | CEFPODOXIME PROXETIL | 1 | Oral | 200 MG, 2X/DAY | 400 | MG | U | 0 | 200 | MG | TABLET | BID | |||
126274947 | 12627494 | 39 | C | CURAN | RANITIDINE HYDROCHLORIDE | 1 | Oral | 75 MG, 2X/DAY | 0 | 75 | MG | BID | |||||||
126274947 | 12627494 | 40 | C | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0.25MG AS REQUIRED | 0 | .25 | MG | ||||||||
126274947 | 12627494 | 41 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 10.0MG AS REQUIRED | 0 | 10 | MG | ||||||||
126274947 | 12627494 | 42 | C | MACPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 30.0MG AS REQUIRED | 0 | 30 | MG | ||||||||
126274947 | 12627494 | 43 | C | MACPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | 5.0MG AS REQUIRED | 0 | 5 | MG | ||||||||
126274947 | 12627494 | 44 | C | PENIRAMIN | 2 | Intravenous (not otherwise specified) | 2.0MG AS REQUIRED | 0 | 2 | MG | |||||||||
126274947 | 12627494 | 45 | C | MUCOPECT | 2 | Oral | 30.0MG AS REQUIRED | 0 | 30 | MG | |||||||||
126274947 | 12627494 | 46 | C | DEXLANSOPRAZOLE | DEXLANSOPRAZOLE | 1 | Oral | 30.0MG AS REQUIRED | 0 | 30 | MG | ||||||||
126274947 | 12627494 | 47 | C | ALUMINIUM SUCRALFATE | 2 | Oral | 15.0ML AS REQUIRED | 0 | 15 | ML | |||||||||
126274947 | 12627494 | 48 | C | MEGESTROL ACETATE. | MEGESTROL ACETATE | 1 | Oral | 10.0ML AS REQUIRED | 0 | 10 | ML | ||||||||
126274947 | 12627494 | 49 | C | APREPITANT. | APREPITANT | 1 | Oral | 125 MG, WEEKLY | 0 | 125 | MG | /wk | |||||||
126274947 | 12627494 | 50 | C | APREPITANT. | APREPITANT | 1 | Oral | 80 MG, WEEKLY | 0 | 80 | MG | /wk | |||||||
126274947 | 12627494 | 51 | C | GASTER | FAMOTIDINE | 1 | Intravenous (not otherwise specified) | 20 MG, 2X/DAY | 240 | MG | 0 | 20 | MG | BID | |||||
126274947 | 12627494 | 52 | C | ARESTAL | LOPERAMIDE OXIDE | 1 | Oral | 1.0MG AS REQUIRED | 0 | 1 | MG | ||||||||
126274947 | 12627494 | 53 | C | SCOPOLAMINE /00008701/ | SCOPOLAMINE | 1 | Oral | 10.0MG AS REQUIRED | 0 | 10 | MG | ||||||||
126274947 | 12627494 | 54 | C | EPOCELIN | 2 | Intravenous (not otherwise specified) | 2 G, 3X/DAY | 42 | G | 0 | 2 | G | TID | ||||||
126274947 | 12627494 | 55 | C | TRIDOL | TRAMADOL HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 50 MG, 1X/DAY | 50 | MG | 0 | 50 | MG | QD | |||||
126274947 | 12627494 | 56 | C | METHYSOL | 2 | Intravenous (not otherwise specified) | 55 MG, 1X/DAY | 275 | MG | 0 | 55 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126274947 | 12627494 | 1 | Oesophageal adenocarcinoma |
126274947 | 12627494 | 4 | Oesophageal adenocarcinoma |
126274947 | 12627494 | 23 | Oesophageal adenocarcinoma |
126274947 | 12627494 | 29 | Oesophageal adenocarcinoma |
126274947 | 12627494 | 35 | Oesophageal adenocarcinoma |
126274947 | 12627494 | 38 | Infection prophylaxis |
126274947 | 12627494 | 39 | Abdominal pain upper |
126274947 | 12627494 | 40 | Premedication |
126274947 | 12627494 | 41 | Premedication |
126274947 | 12627494 | 42 | Premedication |
126274947 | 12627494 | 44 | Premedication |
126274947 | 12627494 | 45 | Nasopharyngitis |
126274947 | 12627494 | 46 | Abdominal pain upper |
126274947 | 12627494 | 47 | Abdominal pain upper |
126274947 | 12627494 | 48 | Decreased appetite |
126274947 | 12627494 | 49 | Premedication |
126274947 | 12627494 | 51 | Abdominal pain upper |
126274947 | 12627494 | 52 | Diarrhoea |
126274947 | 12627494 | 53 | Diarrhoea |
126274947 | 12627494 | 54 | Infection prophylaxis |
126274947 | 12627494 | 55 | Pyrexia |
126274947 | 12627494 | 56 | Diarrhoea |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126274947 | 12627494 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126274947 | 12627494 | Colitis | |
126274947 | 12627494 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126274947 | 12627494 | 1 | 20160510 | 20160510 | 0 | |
126274947 | 12627494 | 2 | 20160609 | 20160609 | 0 | |
126274947 | 12627494 | 3 | 20160705 | 20160705 | 0 | |
126274947 | 12627494 | 4 | 20160510 | 20160510 | 0 | |
126274947 | 12627494 | 5 | 20160510 | 20160511 | 0 | |
126274947 | 12627494 | 6 | 20160511 | 20160512 | 0 | |
126274947 | 12627494 | 7 | 20160524 | 20160524 | 0 | |
126274947 | 12627494 | 8 | 20160524 | 20160525 | 0 | |
126274947 | 12627494 | 9 | 20160525 | 20160526 | 0 | |
126274947 | 12627494 | 10 | 20160609 | 20160609 | 0 | |
126274947 | 12627494 | 11 | 20160609 | 20160610 | 0 | |
126274947 | 12627494 | 12 | 20160610 | 20160611 | 0 | |
126274947 | 12627494 | 13 | 20160621 | 20160621 | 0 | |
126274947 | 12627494 | 14 | 20160621 | 20160622 | 0 | |
126274947 | 12627494 | 15 | 20160622 | 20160623 | 0 | |
126274947 | 12627494 | 16 | 20160705 | 20160705 | 0 | |
126274947 | 12627494 | 17 | 20160705 | 20160706 | 0 | |
126274947 | 12627494 | 18 | 20160706 | 20160707 | 0 | |
126274947 | 12627494 | 19 | 20160707 | 20160707 | 0 | |
126274947 | 12627494 | 20 | 20160907 | 20160907 | 0 | |
126274947 | 12627494 | 21 | 20160908 | 20160908 | 0 | |
126274947 | 12627494 | 22 | 20160909 | 20160909 | 0 | |
126274947 | 12627494 | 23 | 20160510 | 0 | ||
126274947 | 12627494 | 24 | 20160524 | 0 | ||
126274947 | 12627494 | 25 | 20160609 | 0 | ||
126274947 | 12627494 | 26 | 20160621 | 0 | ||
126274947 | 12627494 | 27 | 20160705 | 0 | ||
126274947 | 12627494 | 28 | 20160907 | 0 | ||
126274947 | 12627494 | 29 | 20160510 | 20160510 | 0 | |
126274947 | 12627494 | 30 | 20160524 | 20160524 | 0 | |
126274947 | 12627494 | 31 | 20160609 | 20160609 | 0 | |
126274947 | 12627494 | 32 | 20160621 | 20160621 | 0 | |
126274947 | 12627494 | 33 | 20160705 | 20160705 | 0 | |
126274947 | 12627494 | 34 | 20160907 | 20160907 | 0 | |
126274947 | 12627494 | 35 | 20160510 | 20160510 | 0 | |
126274947 | 12627494 | 36 | 20160609 | 20160609 | 0 | |
126274947 | 12627494 | 37 | 20160705 | 20160705 | 0 | |
126274947 | 12627494 | 38 | 20160717 | 20160718 | 0 | |
126274947 | 12627494 | 39 | 20160717 | 20160718 | 0 | |
126274947 | 12627494 | 40 | 20160524 | 0 | ||
126274947 | 12627494 | 41 | 20160524 | 0 | ||
126274947 | 12627494 | 42 | 20160524 | 0 | ||
126274947 | 12627494 | 43 | 20160525 | 0 | ||
126274947 | 12627494 | 44 | 20160524 | 0 | ||
126274947 | 12627494 | 45 | 20160609 | 0 | ||
126274947 | 12627494 | 46 | 20160609 | 0 | ||
126274947 | 12627494 | 47 | 20160609 | 0 | ||
126274947 | 12627494 | 48 | 20160622 | 0 | ||
126274947 | 12627494 | 49 | 20160705 | 0 | ||
126274947 | 12627494 | 50 | 20160706 | 0 | ||
126274947 | 12627494 | 51 | 20160711 | 20160716 | 0 | |
126274947 | 12627494 | 52 | 20160710 | 20160716 | 0 | |
126274947 | 12627494 | 53 | 20160710 | 20160716 | 0 | |
126274947 | 12627494 | 54 | 20160710 | 20160716 | 0 | |
126274947 | 12627494 | 55 | 20160713 | 20160713 | 0 | |
126274947 | 12627494 | 56 | 20160712 | 20160716 | 0 |